What are the components of the lethal triad in trauma resuscitation, and how should they be addressed?

What are the components of the lethal triad in trauma resuscitation, and how should they be addressed?

• A. Hypothermia, acidosis, coagulopathy; address with warming, balanced blood products, and rapid hemorrhage control
• B. Hyperthermia, alkalosis, hypercoagulability
• C. Hypoxia, anemia, dehydration
• D. Infection, inflammation, edema

Answer: (A)

In trauma resuscitation, the lethal triad comprises hypothermia, acidosis, and coagulopathy. These three problems feed one another: ongoing bleeding leads to poor perfusion and lactic acidosis, cold environments and cold IV fluids worsen body temperature, and coagulopathy both promotes more bleeding and worsens the cycle. The way to combat this trio is to break the cycle with three focused actions. First, prevent and treat hypothermia by warming the patient and using warmed fluids and blood products. Second, address acidosis by ensuring adequate perfusion and oxygen delivery, avoiding dilutional and excessive crystalloid resuscitation, and using blood products early to support coagulation and oxygen transport. Third, correct coagulopathy with damage-control resuscitation: rapid hemorrhage control, balanced transfusion of blood products (red cells, plasma, and platelets in a 1:1:1 approach when possible), and adjuncts like tranexamic acid when appropriate. Early coagulation testing or viscoelastic-guided therapy helps tailor treatment and prevent further bleeding. The other options describe states or problems that do not reflect the clinically critical triad driving mortality in uncontrolled hemorrhage.

In trauma resuscitation, the lethal triad comprises hypothermia, acidosis, and coagulopathy. These three problems feed one another: ongoing bleeding leads to poor perfusion and lactic acidosis, cold environments and cold IV fluids worsen body temperature, and coagulopathy both promotes more bleeding and worsens the cycle. The way to combat this trio is to break the cycle with three focused actions. First, prevent and treat hypothermia by warming the patient and using warmed fluids and blood products. Second, address acidosis by ensuring adequate perfusion and oxygen delivery, avoiding dilutional and excessive crystalloid resuscitation, and using blood products early to support coagulation and oxygen transport. Third, correct coagulopathy with damage-control resuscitation: rapid hemorrhage control, balanced transfusion of blood products (red cells, plasma, and platelets in a 1:1:1 approach when possible), and adjuncts like tranexamic acid when appropriate. Early coagulation testing or viscoelastic-guided therapy helps tailor treatment and prevent further bleeding. The other options describe states or problems that do not reflect the clinically critical triad driving mortality in uncontrolled hemorrhage.